Robert Philibert
Chief Tech/Sci/R&D Officer at CARDIO DIAGNOSTICS HOLDINGS, INC.
Net worth: 1 M $ as of 2024-04-29
Profile
Robert Philibert is the founder of Behavioral Diagnostics, LLC (founded in 2009) and Cardio Diagnostics, Inc. (founded in 2017).
He is currently the Chief Medical Officer & Director at Cardio Diagnostics Holdings, Inc. (since 2022) and a Professor at the University of Iowa (since 1998).
He completed his undergraduate degree at the University of Iowa.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-31 | 1,649,792 ( 7.64% ) | 1 M $ | 2024-04-29 |
Robert Philibert active positions
| Companies | Position | Start |
|---|---|---|
| CARDIO DIAGNOSTICS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 2022-10-24 |
Cardio Diagnostics, Inc.
 Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The private company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Founder | 2017-04-30 |
| University of Iowa | Corporate Officer/Principal | 1997-12-31 |
Former positions of Robert Philibert
| Companies | Position | End |
|---|---|---|
| Behavioral Diagnostics, LLC | Founder | - |
Training of Robert Philibert
| University of Iowa | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The private company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Health Services |
| Cardio Diagnostics Holdings, Inc. | |
| Behavioral Diagnostics, LLC |
- Stock Market
- Insiders
- Robert Philibert